MGNI... SNORenz @ 22 cents Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : MGNI... SNORenz @ 22 cents

MGNI 14.79

+0.7%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

To: Arizona997 who started this subject	11/6/2001 12:25:03 PM
From: Arizona997	of 6

MGNI will launch pain product in Walgreen's Drug Stores nationwide... "In addition, the company has another product now being prepared for a January launch. More than 150 million Americans suffer from some sort of pain and over 50 million from arthritis. Med Gen's soon to be released 4 in 1 Pain Relief Roll On product, PAINenz™ looks very interesting. Aimed at the multi-billion dollar pain relief market, PAINenz™ has a unique formula and application. PAINenz™ has been proven extremely effective in a clinical study performed by Clinical Research Laboratories, Inc. A five day use study of PAINenz™ was conducted by following the applicable guidelines and regulations established by U.S. Regulatory Agencies. PAINenz™ was proven to be over 85% effective in the five day study. The conclusion reads as follows: "Under the conditions of this study, the test product identified as PAINenz™ demonstrated statistical significant pain and stiffness reduction following each use of the test material. The test material exhibited a cumulative decrease in both pain and stiffness following five (5) days of use. The product is being readied for a launch in Walgreens Drug stores nationwide." *from Stockprowler.com Report 11-4-2001

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext